Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models
Acetaminophen is commonly used as a reference hepatotoxin to demonstrate that in vitro human liver platforms can emulate features of clinical drug-induced liver injury. However, the induction of substantial cell death in these models typically requires acetaminophen concentrations (∼10 mM) far higher than blood concentrations of the drug associated with clinical hepatotoxicity (∼1 mM). Using the cytochrome P450 inhibitor 1-aminobenzotriazole, we show that acetaminophen toxicity in cultured human, mouse, and rat hepatocytes is not dependent on N-acetyl-p-benzoquinonimine formation, unlike the in vivo setting. This finding highlights the limitation of using acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models. Hence, we make recommendations on the selection of reference hepatotoxins for this purpose.
Authors
- Dennis Reddyhoff (ORCID: https://orcid.org/0000-0002-4971-2346)
- Christopher E. Goldring (ORCID: https://orcid.org/0000-0002-8951-2226)
- Rafael Díaz-Nieto
- Ciarán Fisher
- Ian M. Copple (ORCID: https://orcid.org/0000-0003-4101-1913)
- Rowena Sison‐Young
- Iain Gardner (ORCID: https://orcid.org/0000-0002-4811-8513)
- Lucia A Livoti
Institutions
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- Age UK (GB)
- Predictive Science (United States) (US)
Publication Details
- Journal
- Toxicological Sciences
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1093/toxsci/kfae133
- Citations
- 5
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- European Federation of Pharmaceutical Industries and Associations
- European Commission
- Medical Research Council